Profile data is unavailable for this security.
About the company
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
- Revenue in USD (TTM)15.85bn
- Net income in USD-559.00m
- Incorporated1944
- Employees35.00k
- LocationTeva Pharmaceutical Industries Ltd124 Dvora Hanevi'a StTEL AVIV-YAFO 6944020IsraelISR
- Phone+972 39148213
- Fax+972 39234050
- Websitehttps://www.tevapharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exact Sciences Corp | 2.50bn | -204.15m | 10.67bn | 6.50k | -- | 3.39 | 4,340.06 | 4.27 | -1.14 | -1.14 | 13.81 | 17.34 | 0.3937 | 5.32 | 13.82 | 384,579.40 | -3.22 | -9.71 | -3.47 | -10.60 | 73.83 | 74.10 | -8.17 | -28.21 | 2.07 | -- | 0.4311 | -- | 19.93 | 40.63 | 67.26 | -- | -3.71 | -- |
United Therapeutics Corporation | 2.33bn | 984.80m | 11.10bn | 1.17k | 11.90 | 1.85 | 10.70 | 4.77 | 19.82 | 19.82 | 46.83 | 127.23 | 0.3523 | 2.41 | 9.32 | 1,992,723.00 | 14.91 | 10.38 | 16.33 | 11.27 | 88.94 | 91.47 | 42.31 | 29.25 | 4.28 | -- | 0.1047 | 0.00 | 20.20 | 7.41 | 35.40 | 10.89 | 4.55 | -- |
Natera Inc | 1.08bn | -434.80m | 11.16bn | 3.28k | -- | 14.26 | -- | 10.31 | -3.80 | -3.80 | 9.41 | 6.40 | 0.7634 | 15.49 | 4.14 | 329,851.00 | -30.66 | -36.17 | -39.20 | -46.60 | 45.52 | 45.88 | -40.16 | -56.15 | 3.96 | -- | 0.3219 | -- | 31.99 | 33.26 | 20.63 | -- | 58.81 | -- |
Incyte Corp | 3.70bn | 597.60m | 11.49bn | 2.52k | 19.36 | 2.21 | 16.89 | 3.11 | 2.64 | 2.64 | 16.36 | 23.14 | 0.5855 | 4.43 | 5.32 | 1,464,203.00 | 9.47 | 9.07 | 11.69 | 11.02 | 93.71 | 94.97 | 16.17 | 13.68 | 3.69 | -- | 0.0062 | 0.00 | 8.87 | 14.45 | 75.42 | 40.41 | -15.06 | -- |
Charles River Lbrtrs ntrntl Inc | 4.13bn | 474.62m | 11.73bn | 20.00k | 24.68 | 3.25 | 14.77 | 2.84 | 9.23 | 9.23 | 80.25 | 70.06 | 0.5228 | 8.19 | 5.39 | 206,470.50 | 6.08 | 6.46 | 7.09 | 7.62 | 36.89 | 36.99 | 11.63 | 11.58 | 1.16 | 4.97 | 0.4203 | 0.00 | 3.86 | 12.75 | -2.39 | 16.69 | 17.86 | -- |
Sarepta Therapeutics Inc | 1.24bn | -535.98m | 11.96bn | 1.31k | -- | 13.90 | -- | 9.62 | -6.15 | -6.15 | 13.46 | 9.17 | 0.389 | 0.5708 | 4.04 | 946,222.30 | -16.77 | -21.63 | -20.94 | -25.75 | 87.91 | 86.65 | -43.11 | -77.05 | 3.45 | -- | 0.5903 | -- | 33.26 | 32.80 | 23.81 | -- | 6.30 | -- |
Medpace Holdings Inc | 1.96bn | 312.32m | 12.08bn | 5.80k | 39.72 | 17.94 | 35.53 | 6.15 | 9.81 | 9.81 | 61.73 | 21.72 | 1.23 | -- | 7.31 | 332,680.00 | 19.58 | 13.94 | 46.20 | 23.18 | 27.99 | 28.84 | 15.92 | 15.23 | -- | -- | 0.00 | -- | 29.17 | 21.76 | 15.26 | 31.17 | 17.99 | -- |
Viatris Inc | 15.43bn | 54.70m | 13.62bn | 38.00k | 270.97 | 0.6729 | 4.87 | 0.883 | 0.0423 | 0.0423 | 12.81 | 17.05 | 0.3158 | 2.49 | 5.09 | 405,971.10 | 0.112 | 0.0887 | 0.1315 | 0.1061 | 43.64 | 40.29 | 0.3546 | 0.2891 | 1.22 | 2.79 | 0.4696 | 560.11 | -5.14 | 6.17 | -97.37 | -30.53 | -16.88 | -- |
Neurocrine Biosciences, Inc. | 1.89bn | 249.70m | 13.86bn | 1.40k | 56.66 | 6.09 | 51.13 | 7.34 | 2.43 | 2.43 | 18.84 | 22.61 | 0.6716 | 1.08 | 4.78 | 1,347,929.00 | 8.89 | 9.77 | 11.28 | 12.19 | 97.90 | 98.51 | 13.23 | 14.79 | 2.40 | -- | 0.0708 | -- | 26.76 | 33.13 | 61.62 | 63.90 | 2.67 | -- |
Teva Pharmaceutical Industries Ltd (ADR) | 15.85bn | -559.00m | 14.79bn | 35.00k | -- | 1.98 | 27.65 | 0.9336 | -0.5005 | -0.5005 | 14.12 | 6.70 | 0.3622 | 2.00 | 4.46 | 452,729.90 | -1.41 | -3.14 | -1.98 | -4.29 | 50.33 | 48.14 | -3.90 | -9.87 | 0.6911 | 3.55 | 0.7094 | -- | 6.17 | -3.42 | 77.15 | -- | -4.17 | -- |
Biomarin Pharmaceutical Inc | 2.47bn | 205.46m | 15.59bn | 3.40k | 77.78 | 3.07 | 50.18 | 6.31 | 1.06 | 1.06 | 12.77 | 26.74 | 0.3715 | 0.4993 | 4.00 | 726,740.40 | 3.09 | 0.7773 | 3.54 | 0.8825 | 79.22 | 76.30 | 8.31 | 2.24 | 1.70 | -- | 0.1766 | 0.00 | 15.42 | 10.16 | 18.43 | -- | -5.74 | -- |
Alnylam Pharmaceuticals, Inc. | 1.83bn | -440.24m | 18.10bn | 2.10k | -- | -- | -- | 9.90 | -3.59 | -3.59 | 14.46 | -1.75 | 0.4957 | 2.85 | 8.43 | 870,615.30 | -11.94 | -26.56 | -15.61 | -32.77 | 83.02 | 83.66 | -24.08 | -94.26 | 2.99 | -2.11 | 1.28 | -- | 76.23 | 89.45 | 61.08 | -- | -13.29 | -- |
Data as of Apr 26 2024. Currency figures normalised to Teva Pharmaceutical Industries Ltd's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
Ion Asset Management (Israel) Ltd.as of 31 Dec 2023 | 40.33m | 3.60% |
Lingotto Investment Management LLPas of 31 Dec 2023 | 34.46m | 3.07% |
Phoenix Investments House Ltd.as of 31 Dec 2023 | 34.38m | 3.07% |
Clal Pension & Provident Funds Ltd.as of 31 Dec 2023 | 32.80m | 2.93% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 31.96m | 2.85% |
Migdal Insurance Co. Ltd. (Investment Portfolio)as of 31 Dec 2023 | 28.92m | 2.58% |
Harel Mutual Funds Ltd.as of 31 Dec 2023 | 28.53m | 2.55% |
Menora Mivtachim Insurance Ltd.as of 31 Dec 2023 | 28.13m | 2.51% |
Slate Path Capital LPas of 31 Dec 2023 | 26.23m | 2.34% |
Rubric Capital Management LPas of 31 Dec 2023 | 18.23m | 1.63% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.